创科局确认晶苑(02232.HK)为政府可重用口罩生产商 今早股价高开10%
创新及科技局常任秘书长蔡淑娴今早接受电台访问时承认,政府派发予全港市民的可重用口罩生产商为晶苑国际(02232.HK),并於其越南厂房生产。她解释,当初不公开生产商名称,是不想「麻烦对方」,在徵求对方同意後决定公开生产商身分。
她又指,除晶苑参与生产外,土瓜湾联业制衣亦有协助做较细的生产线,完成的口罩交予在大埔工业村的龙达制衣负责消毒工作,南丰纱厂亦无偿借出车间。
她补充,生产重用口罩需要臭氧消毒和无尘车间的设备生产,但香港不是有太多生产商能提供相关设备,亦有公司因为内地和其他地方的生产线停工、原料被禁出口等问题,不能生产。
晶苑股价今早高开10%报2.2元,曾高见2.32元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.